ZebiAI Therapeutics
Analysis completed on 3/17/2026
ZebiAI Therapeutics possesses strong underlying technical innovation and utility through its ML-driven drug discovery platform and partnership with Google Accelerated Science. However, the submission contains highly suspicious, unverifiable, and contradictory claims regarding audience reach ('everyone') and traction ('most people have used my product'). These red flags result in severe penalties to response quality, reach, and traction metrics.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline